Skip to main content
editorial
. 2021 May 20;10(6):27. doi: 10.1167/tvst.10.6.27

Table 1.

Primers for Amplifying Receptors

Gene Forward Primer Reverse Primer
HEPOR CTTGTGGTATCTGACTCT ATAAGGCTGTTCTCATAAG
HTGFBR1 GATTACCAACTGCCTTAT TTAGCCATTACTCTCAAG
HTGFBR2 GAATATAACACCAGCAATC CAGTAGAAGATGATGATGA
HTGFBR3 GTCTACTATAACTCCATTGT TCTCCTTCATCCATATCT
PTPRN AGTGAAGGAGATTGACAT CAAATTCAAACTGGTCCT
PTGER4 TGGTCATCTTACTCATTG GCATTTCTCTTGTATGTATAG
PTGFR AATGATGTTAAGTGGTGT ATGTCTTCTGTGTTGTAG
PTGER2 ATGAATGAAACCTCTTCC CATCTTGTGTTCTTAATGAA
PTGER1 CTTGTCGGTATCATGGTG GTAGGATGTACACCCAAG
EDIL3 AGTTACTGGTGTGATTAC TCATTACTGTAGGCAATT
MEGF9 GTCATCATCATTGTTGTG CTTCATTGCCATCATCTT

EDIL3, EGF-like repeat and discoidin I-like domain-containing protein 3; HEPOR, human erythropoietin receptor; HTGFBR1, 2, and 3, human transforming growth factor-β receptor 1, 2, and 3; MEGF9, multiple epidermal growth factor-like-domains 9; PTGER1, 2, and 4, prostaglandin E receptor 1, 2, and 4; PTGFR, prostaglandin F2-alpha receptor; PTPRN, protein tyrosine phosphatase receptor-type N.